Zavegepant, sold under the brand name Zavzpret, is a medication used for the treatment of migraine.

[1] Zavegepant is a calcitonin gene-related peptide receptor antagonist.

[1] The most common adverse reactions include taste disorders, nausea, nasal discomfort, and vomiting.

[1] Zavegepant was approved for medical use in the United States in March 2023.

[1][2][3][4] Zavegepant is indicated for the acute treatment of migraine with or without aura in adults.